Building Radiotherapy Capacity for Treatment of Cervical Cancer in India

Similar documents
CT Guided Contouring: Challenges and Pitfalls

Locally advanced disease & challenges in management

Basic Concepts in Image Based Brachytherapy (GEC-ESTRO Target Concept & Contouring)

Challenge and Scope of Radiation Oncology in Cancer Care. Tata Memorial Center, INDIA

Radiation Therapy in Africa

CT Guided Contouring: Challenges and Pitfalls

NEWER RADIATION (3 D -CRT, IMRT, IGRT) TECHNIQUES FOR CERVICAL CANCERS (COMMON PELVIC TUMORS)

Recent Advances and current status of radiotherapy for cervix cancer

I. Equipments for external beam radiotherapy

RADIOTHERAPY- CURRENT SITUATION AND FUTURE TRENDS

Radiotherapy & Cervical Cancer Dr Mary McCormack Consultant Clinical Oncologist University College Hospital, London,UK

Structure of Postgraduate Training in Radiotherapy in India. Dr. G.K. Rath. Professor & Head Department of Radiation Oncology AIIMS, New Delhi

Patterns of Care in Patients with Cervical Cancer:


Brachytherapy in India a long road ahead

Johannes C. Athanasios Dimopoulos

The 1 st. FARO Council Meeting. May 30, 2015 Kyoto International conference center, Japan

Local Organiser: Madhup Rastogi, Radiation Oncologist, Ram Manohar Lohia Institute of Medical Sciences, Lucknow

The Evolution of RT Techniques for Gynaecological Cancers in a developing country context

Collection of Recorded Radiotherapy Seminars

Access to Radiotherapy: Bridging The Gap Through Innovation

Minimizing Disparity in Cervical Cancer Cure Through Improved Access to Care

HALF. Who gets radiotherapy? Who gets radiotherapy? Half of all cancer patients get radiotherapy. By 1899 X rays were being used for cancer therapy

University Medical Center Utrecht The Netherlands

Hypofractionated Radiotherapy for breast cancer: Updated evidence

Cervix Cancer Research Network

Brachytherapy in Africa

MRI Guided GYN Brachytherapy: Clinical Considerations

Oral cavity cancer Post-operative treatment

Partial Breast Irradiation using adaptive MRgRT

Country Presentations of FNCA FY2007 Workshop on Radiation Oncology

Interstitial Brachytherapy. Low dose rate brachytherapy. Brachytherapy alone cures some cervical cancer. Learning Objectives

Session 17 Practical Implementation of New Technologies in Low-to-Middle Income Countries

INVESTOR MEETING ASTRO 2013

High-Dose-Rate Orthogonal Intracavitary Brachytherapy with 9 Gy/Fraction in Locally Advanced Cervical Cancer: Is it Feasible??

Office: Cell Ph:

8/2/2012. Mapping Anatomically Sensitive Bone Marrow Regions. Hematopoietic Functions of Bone Marrow. Radiosensitivity of Bone Marrow

EMBRACE- Studien Analysen und Perspektiven

Hypofractionated RT in Cervix Cancer. Anuja Jhingran, MD

Image guided brachytherapy in cervical cancer Clinical Aspects

Elekta: Emerging markets

Course Directors : Teaching Staff : Guest Lecturer: Local Organiser: ESTRO coordinators: Melissa Vanderijst and Marta Jayes, project managers (BEL)

ARROCase: Locally Advanced Endometrial Cancer

INTRODUCTION PATIENT. J. Radiat. Res., 52, (2011)

Enterprise Interest None

Advances in Gynecologic Brachytherapy

Oral Cavity Cancer Combined modality therapy

Ritu Raj Upreti, S. Dayananda, R. L. Bhalawat*, Girish N. Bedre*, D. D. Deshpande

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

Lead Group Log. Wael M.S.A Gawad. M.D -Ph.D FRCS (Eng) Department of Surgical Oncology National Cancer Institute NCI-Cairo University - EGYPT

FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE. Geoffrey S. Ibbott, Ph.D. June 20, 2017

Current Status of Accelerated Partial Breast Irradiation. Julia White MD Professor, Radiation Oncology

SUSTAINING ACCESS TO HIGH QUALITY RADIOTHERAPY CARE: A LMIC PERSPECTIVE

Cervix Cancer Research Network (CCRN)

3D ANATOMY-BASED PLANNING OPTIMIZATION FOR HDR BRACHYTHERAPY OF CERVIX CANCER

Linking DVH-parameters to clinical outcome. Richard Pötter, Medical University of Vienna, General Hospital of Vienna, Austria

Who Should Know Radiation Oncology Coding?

Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer

EMERGING MARKETS. Thomas Pollatz Marketing Manager Varian Brachytherapy. Gynecologic Cancer InterGroup Cervix Cancer Research Network

7/30/2017. One World Medical Physics: Challenges and Opportunities in Cancer Care. Worldwide Demographic Shift

Reena Phurailatpam. Intensity Modulated Radiation Therapy of Medulloblastoma using Helical TomoTherapy: Initial Experience from planning to delivery

Cervical Cancer: 2018 FIGO Staging

GYN Brachytherapy at General Hospital / Medical University of Vienna. Richard Pötter

Albert Lisbona Medical Physics Department CLCC Nantes Atlantique a

ACCELERATED BREAST IRRADIATION EVOLVING PARADIGM FOR TREATMENT OF EARLY STAGE BREAST CANCER

Jean Pouliot, PhD Professor and Vice Chair, Department of Radiation Oncology, Director of Physics Division

External Beam Radiotherapy for Prostate Cancer

Quimio Radioterapia en Cancer de Cervix

Therapeutic Medical Physics. Stephen J. Amadon Jr., Ph.D., DABR

Particle (proton) Therapy Randomized trials vs. Prospective registry. Andrew K. Lee, MD, MPH Associate Professor Department of Radiation Oncology

Five patients needing radiation but no in-country access. Memory Nsingo 15 December 2015

The Current & Future State of Particle Therapy

Advances in external beam radiotherapy

Closing of Nucletron acquisition Building a stronger position in the cancer care market. September 15, 2011

GCIG Cervix Committee: Chicago, USA May 30th Satoru Sagae (JGOG) Bradley Monk (GOG)

Healthcare Professional Guide

Intensity-Modulated and Image- Guided Radiation Treatment. Outline. Conformal Radiation Treatment

Radiotherapy physics & Equipments

New Radiation Health Technologies Challenges, Opportunities, Limitations

Understanding Radiation Therapy. For Patients and the Public

Overview of Advanced Techniques in Radiation Therapy

Management of Prostate Cancer in Africa. Dr David Anderson Clinical Oncologist Groote Schuur Hospital February 2017

HYPERTHERMIA in CERVIX and VAGINA CANCER. J. van der Zee

Comparison of high and low energy treatment plans by evaluating the dose on the surrounding normal structures in conventional radiotherapy

Stage III Non-Small Cell Lung Cancer, Is There Any Progress? HARMESH R NAIK, MD. KARMANOS CANCER INSTITUTE 2/24/99

Full Automation in Radiotherapy

Adjuvant Therapies in Endometrial Cancer. Emma Hudson

PROSTATE CANCER, Radiotherapy ADVANCES in RADIOTHERAPY for PROSTATE CANCER

HDR Brachytherapy I: Overview of Clinical Application and QA. Disclosures. Learning Objectives 7/23/2014. Consultant, Varian Medical Systems

Guidelines for the use of inversely planned treatment techniques in Clinical Trials: IMRT, VMAT, TomoTherapy

Management of Cervical Cancer in Resource Limited Settings

ICRT รศ.พญ.เยาวล กษณ ชาญศ ลป

Palliative RT in Ovarian cancer

Hot topics in Radiation Oncology for the Primary Care Providers

Course Directors: Teaching Staff: Guest Lecturers: Local Organiser: ESTRO coordinator: Melissa Vanderijst, project manager (BE)

Implementation of advanced RT Techniques

JMSCR Vol 06 Issue 12 Page December 2018

Hong Kong Hospital Authority Convention 2018

REVISITING ICRU VOLUME DEFINITIONS. Eduardo Rosenblatt Vienna, Austria

ESGO-ESTRO-ESP Cervical Cancer Clinical Practice Guidelines Management of early stages: algorithms focusing on the histological data

Transcription:

Building Radiotherapy Capacity for Treatment of Cervical Cancer in India Umesh Mahantshetty, Professor, Radiation Oncology & GYN DMG Member On behalf of Department of Radiation Oncology & Medical Physics Tata Memorial Hospital Mumbai, India

DISCLOSURES NONE!

FIVE MOST COMMON CANCERS IN INDIAN WOMEN ESTIMATED No. OF NEW CASES & DEATHS : YEAR 2012 * Breast Cervix uteri Colorectum 20789 27415 70218 67, 477 144937 122,844 Ovary 19549 26834 Lip, oral cavity 15631 23161 0 20000 40000 60000 80000 100000 120000 140000 160000 Mortality Incidence * estimates based on GLOBOCAN 2012

AGE STANDARDISED (WORLD POPULATION) WOMEN CANCER INCIDENCE RATES PER 100,000 POPULATION IN FEMALES 40 35 30 25 20 15 10 5 0 23.2 23.3 19.3 20.1 21.2 16.6 4.8 33.7 31.3 30.3 28.2 27.5 24.6 19.3 20.2 17.4 15.7 12.9 7.2 7.2 6.5 7.2 7.6 8.3 6.9 1.3 1.4 1.6 2.3 2.5 2.4 3.2 3.6 10.5 7.3 5.3 1970 1975 1980 1985 1990 1995 2000 2005 2010 Year Breast Cervix Uteri Ovary Corpus Uteri SOURCE : BOMBAY CANCER REGISTRY, REPORTS 1970-2010

Radiation therapy facilities in India: Update from Atomic energy Regulatory Board March 2016 400 350 INDIAN POPULATION : 1.2 billion LA 300 250 COBALT BT Number of units 200 150 100 Unit Year 50 0 1980 1985 1990 1995 2000 2005 2010 2014 2016 Co 60 80 87 130 185 245 256 247 238 224 LA 2 6 13 23 34 68 157 308 347 Brachy 8 11 31 49 66 73 163 232 251

International norm: 2 machines/million population India : 0.33/million MAJOR DISPARITY - Academic Vs Corporate - Urban Vs Rural - Health care Accessibility - Manpower & Expertise LMIC s: Kannan V et al; IJROBP 94 (4) 2016 Datta et al. Telemedicine and e-health 21 (7) July 2015

NATIONAL CANCER REGISTRY PROGRAM (NCRP) INDIAN COUNCIL FOR MEDICAL RESEARCH 2012-2014 REPORTS POPULATION BASED REGISTERIES HOSPITAL BASED REGISTERIES

8

TATA MEMORIAL CENTRE, MUMBAI, INDIA TERTIARY CANCER CENTRE EXPERIENCE ADVANCED CENTRE FOR TREATMENT RESEARCH AND EDUCATION IN CANCER

TMC: Radiotherapy Paraphernalia TATA MEMORIAL HOPSITAL Accelerators 1. UNIQUE 2. TRUEBEAM 3. Clinac 6Ex (Varian), 120 MLC 4. Trilogy (Varian) 5. Novalis TX (Varian) 6. Tomotherapy Telecobalt 1. Theratron 780 (MDS) 2. Theratron 780C (MDS) 3. Elite 80 (MDS) 4. Equinox 80 (MDS) Simulators 1. Ximatron (Varian) 2. Somatom CT-Sim (Siemens) 3. Fly-through (GE) 4. C-Arm 5. USG Brachytherapy 1. MicroSelectron-HDR V30 2. MicroSelectron-HDR V18 ACTREC Accelerators 1. TRUEBEAM 2. Tomotherapy Telecobalt 1. Bhabhatron II Simulator 1. Oldelf (Nucletron) Brachytherapy IBU 1. MicroSelectron-HDR V30

No. of Cervix Cancer Cases 18000 16000 14000 12000 10000 8000 6000 4000 2000 0 TRENDS OF CERVICAL CANCER TATA MEMORIAL HOSPITAL : 1941-2015* 16635 15083 13642 12801 9055 4679 2050 8780

Tata Memorial Hospital Cancer Registry (1985-2012) Significant Down Staging! 70.0 68.5 65.3 63.3 60.0 50.0 40.0 30.0 28.2 39.2 35.2 35.0 29.6 28.0 28.8 27.7 54.1 51.7 51.3 46.3 47.1 44.5 34.2 20.0 10.0 17.0 13.8 10.0 11.8 10.8 9.1 9.59.1 10.4 6.1 19.7 17.1 10.6 7.7 10.2 8.07.4 5.2 3.6 9.6 0.0 Stage I Stage II Stage III Stage IV 1985 1989 1993 1997 2000 2002 2004 2006 2008 2012

CERVICAL CANCER RETROSEPCTIVE ANALYSES FIGO Stage IB-IIIB (N = 6234 pts) 1.0 Cum Survival 0.8 0.6 0.4 1988-1994 : 55% at 8 yrs 1984-1987: 45% at 8 yrs 1979-1983 : 35% at 8 yrs 0.2 0.0 P = 0.000 0.00 12.00 24.00 36.00 48.00 60.00 72.00 dfsmonths 84.00 96.00 108.00 120.00 OVERALL OUTCOME WITH RADIATION IMPROVED OVER TIME DUE TO REFINEMENT IN RADIATION DOSES ESP. BRACHYTHERAPY J Cancer Res Ther. 2013 Oct-Dec;9(4):672-9)

CERVICAL CANCER LESSONS LEARNT : 1995-2000 GYNAE JOINT CLINIC : 1978-1979 OUTCOME ANALYSIS IMPROVED COMPLIANCE AND FOLLOW UP UPGRADATION OF RADIATION FACILITIES ACTION PLAN EVIDENCE BASED CLINICAL GUIDELINES PROSPECTIVE TRIALS & INTERNATIONAL COLLABORATION

Tata Memorial Hospital Evidence Based Guidelines EBM MEETINGS : February SERVICE RESEARCH EDUCATION ADOTPED BY MAJORITY OF CENTERS IN INDIA

Prospective Clinical Trials / Studies in Cervical Cancers INVESTIGATOR INITIATED & INTERNATIONAL COLLABORATIVE FIGO Stage I-III : LDR Vs HDR Brachytherapy: 1996 : closed FIGO Stage Ib / IIb : Neo-adjuvant CT + Sx Vs CT + RT : 2003 FIGO Stage IIIb : Chemo-radiation Vs Radiation Alone : 2003 FIGO Stage IIb Locally Adv. Disease IAEA Studies : 3D Conformal Vs Intensity Modulated RT:2004 : Evaluation of PET / CT-PET : 2004 : closed : 2# Vs 4# ICA - HDR by CT Vs No CT:600 pts closed : HIV Positive Pts : CRT Vs RT : 53 /325 pts closed Curcumin Study (II/III) EMBRACE study Vault Cancers : Double blind placebo controlled Ph III study : MR Based Brachytherapy in Cervical Cancers : TOMO Based IMRT / IGRT INTERTECC (NCI funded): Pelvic IMRT with BM Sparing Chemo-radiation

BRACHYTHERAPY IN CERVICAL CANCERS In corporation of Newer Imaging Modalities 2D Planning : Orthogonal X-ray Based (STD) 3D Planning : TMH Experience - MRI: TMH-Initial Experience; Int. J. Gynae Cancer: 2011 - US: TMH Experience; Radio. Oncol 2012 - CT Scan: Interstitial Brachytherapy : Brachytherapy 2013 Routine GYN Practice: - Average 7 (3-9) Cx ICA/ daily + 1-2 Interstitial /wk cases - 3-4 X-ray; 2-3 CT; 1 MR Based Planning

ADVANCES IN GYN BRACHYTHERAPY PLANNING CONVENTIONAL PLANNING MRI BASED PLANNING CT- BASED MUPIT PLANNING

Retrospective and feasibility study : Dec 2006 - May 2008 (N = 24)

Tata Memorial Hospital Participation in International Multicentric Studies - Refine treatment standards - International Recognition (GYN GEC-ESTRO Reasearch Network) TOTAL ACCRUAL : 1400 PATIENTS TMH CONTRIBUTION : 100 PATIENTS IN 3 YEARS A phase II Multicentric International Study by GEC - ESTRO Network

MR IMAGE BASED BRACHYTHERAPY EMBRACE STUDY : 1400 PATIENTS TMH ACCRUAL: 100 PATIENTS Stage IIB and IVA Stage IIIB Stage IVA Stage IIB Stage IIIB P=0.013 P=0.241 IIB IIIB IVA 31 55 08 28 45 07 24 39 06 15 27 04 12 10 02 07 05 00 01 01 00 IIB IIIB IVA 31 55 08 29 51 08 26 43 07 16 28 04 12 10 02 07 05 00 01 01 00 EXCELLANT LOCAL CONTROL RATES FOR ALL STAGES COST BENEFIT ANALYSES : ONGOING

TMH Study 10 11 12 Image Based Brachytherapy in cervical Cancer CT and MRI correlation: Ongoing Research 3.5 3 2.5 2 1.5 1 0.5 0 1 2 3 MR 4 CT Series1 Series2 9 5 8 7 6 10 11 12 3 2.5 2 1.5 1 0.5 0 1 2 3 4 MR CT Series1 Series2 9 5 8 6 7

Image Based Brachytherapy in cervical Cancer TAUS and MRI correlation (TMH data) In collaboration with Peter Mac Melbourne Trans abdominal Ultrasonography : Cost effective imaging modality 32 Applications with MRI Compatible Applicator Anterior Reference Points : 96 % Posterior Reference Points : 72 % Magnitude of Variation (>15%) : < 8% Significant Correlation between the USG and MRI Reference Points Suggest : Use of USG for ICA Planning (21/2 D Planning) Mahantshetty et al. Rad. Onc. Aug. 2011

TATA MEMORIAL CENTRE IN COLLABORATION WITH BARC INDIGENOUS TECHNOLOGY COST EFFECTIVE SOLUTIONS Bhabhatron II INDIGENOUS COBALT MACHINE Siddhartha INDIGENOUS LINEAR ACCELERATOR HDR Brachytherapy Simulator-Imagin

Pramesh CS et al. Lancet Oncol 2014. INFRASTRUCTURE - To minimize the DISPARITY between Rural & Urban set-ups - Support Cost- effective Radiation Facilities in rural India COMMUNITY PROGRAMS - HEALTH INSURANCE SCHEMES : Rural & Urban - Enhance National Cancer Control Program Activitites

TRAINING AND EXCHANGE PROGRAMS IAEA, UICC, GCIG, ESTRO, ASTRO, AROI, IBS ETC. Bilateral Exchange programs WORKSHOPS & TRAINING PROGRAMS : ONGOING - AROI-ESTRO TEACHING COURSES - HANDS ON WORKSHOPS / ANNUAL PRACTICUM MULTI-DISCIPLINARY MEETINGS AT VARIOUS FORUMS - ASSOC. OF Rad. Oncol of India (AROI) : CME s / Conferences - ASSOC. of GYN ONCOl of India (AGOICON) - Women s Cancer Initiative Tata Memorial Centre India

specific problems of the country Pramesh CS et al. Indian J Med Paediatr Oncol 2014;35:226-7. NCG OF INDIA : 2012 (funded by Department of Atomic Energy, Govt of India) Mandate: Linking of cancer centers across India Presently consists of 62 cancer care centres across entire length and breadth of the country and has 4 components - Patient Care Uniform and evidence based cancer care across centers - Education and Training - exchange of expertise and mentoring between the centers, National cancer library - Collaborative Research Research network to conduct cooperative research catering Country specific needs. - Cancer Policy Development of National cancer plan to identify and tackle

TELE-RADIOTHERAPY NETWORK Datta et al. Telemedicine and e-health 21 &7) July 2015

Thank you mahantshettyum@tmc.gov.in